Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Progressive matrix stiffening of tyramine-modified silk fibroin hydrogels governs stage-specific pulmonary fibroblast activation.

bioRxiv : the preprint server for biology·2026
Same author

Modeling ventricular tachycardia in genetic long QT syndrome using engineered cardiac tissues.

Bioactive materials·2026
Same author

Human iPSC-derived macrophages for studying intrinsic and extrinsic factors in cystic fibrosis.

EXO : beyond the cell·2026
Same author

A Simple, Robust Method for Cellular Electrical Interfacing Using Molecular Patterning.

ACS applied materials & interfaces·2026
Same author

Avenues for optimization of cardiac therapeutics by minimally invasive delivery.

Acta biomaterialia·2026
Same author

A custom preservation solution extends the ex vivo availability of living heart valves for transplantation.

JTCVS open·2025

Related Experiment Video

Updated: May 1, 2026

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
06:53

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

2.8K

Bioengineered human tumor within a bone niche.

Aranzazu Villasante1, Alessandro Marturano-Kruik1, Gordana Vunjak-Novakovic1

  • 1Department of Biomedical Engineering, Columbia University, 622 West 168th Street, VC12-234, New York, NY 10032, USA.

Biomaterials
|April 22, 2014
PubMed
Summary
This summary is machine-generated.

This study introduces a bioengineered model for human Ewing's sarcoma, restoring lost cancer cell characteristics. This advanced tumor model aids in identifying potential therapeutic targets for bone cancer.

Keywords:
CancerEwing's sarcomaMicroenvironmentTherapeutic targetsTissue engineeringTumor niche

More Related Videos

Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging
10:03

Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging

Published on: August 1, 2017

11.8K
Tissue Engineering of a Human 3D in vitro Tumor Test System
11:12

Tissue Engineering of a Human 3D in vitro Tumor Test System

Published on: August 6, 2013

21.6K

Related Experiment Videos

Last Updated: May 1, 2026

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
06:53

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

2.8K
Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging
10:03

Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging

Published on: August 1, 2017

11.8K
Tissue Engineering of a Human 3D in vitro Tumor Test System
11:12

Tissue Engineering of a Human 3D in vitro Tumor Test System

Published on: August 6, 2013

21.6K

Area of Science:

  • Oncology
  • Biomedical Engineering
  • Cancer Biology

Background:

  • Traditional cancer research models like monolayer cell cultures and animal studies have limitations in replicating human tumor complexity.
  • Human tumor models often fail to retain critical cancer-specific gene expression and phenotypes.
  • 3D cancer models, such as spheroids and scaffolds, are emerging as improved research tools.

Purpose of the Study:

  • To develop a bioengineered model of human Ewing's sarcoma that accurately mimics the native bone tumor microenvironment.
  • To investigate the recovery of cancer cell transcriptional profiles and phenotypes in the bioengineered model.
  • To identify potential therapeutic targets by analyzing gene expression differences between cultured cells and the native tumor environment.

Main Methods:

  • Development of a bioengineered 3D model using human Ewing's sarcoma cells within a simulated bone tumor niche.
  • Transcriptional profiling to assess gene re-expression in the bioengineered model compared to monolayer cultures.
  • Phenotypic analysis to evaluate the recovery of tumor characteristics like hypoxia, glycolysis, and vasculogenic mimicry.

Main Results:

  • The bioengineered model successfully restored lost transcriptional profiles in cancer cells, including genes related to focal adhesion and cancer pathways.
  • The model re-established the original hypoxic and glycolytic tumor phenotype.
  • Angiogenic and vasculogenic mimicry features, crucial for tumor adaptation, were re-expressed in the bioengineered model.

Conclusions:

  • The bioengineered Ewing's sarcoma model offers high biological fidelity, closely mimicking the native tumor niche.
  • This model facilitates the recovery of critical cancer cell phenotypes and gene expression lost in traditional cultures.
  • Differentially expressed genes identified using this model represent promising therapeutic targets for Ewing's sarcoma treatment.